Litigation Is Being Prepared Against Xarelto
Litigation is being prepared against Xarelto, a drug intended to reduce the risk of stroke and blood clots in people with atrial fibrillation, due to its linkage with uncontrollable internal bleeding. Since 2011, the anticoagulant has not been approved to reduce blood clots in patients with coronary artery disease. The lawsuit focuses on the failure…
Read More